KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Current Deferred Revenue (2016 - 2026)

Bristol Myers Squibb has reported Current Deferred Revenue over the past 18 years, most recently at $168.0 million for Q1 2026.

  • Quarterly Current Deferred Revenue fell 22.58% to $168.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $168.0 million through Mar 2026, down 22.58% year-over-year, with the annual reading at $175.0 million for FY2025, 27.74% up from the prior year.
  • Current Deferred Revenue was $168.0 million for Q1 2026 at Bristol Myers Squibb, down from $175.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $326.0 million in Q1 2022 and troughed at $137.0 million in Q4 2024.
  • The 5-year median for Current Deferred Revenue is $263.0 million (2024), against an average of $250.2 million.
  • Year-over-year, Current Deferred Revenue crashed 50.0% in 2024 and then grew 27.74% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $289.0 million in 2022, then fell by 5.19% to $274.0 million in 2023, then crashed by 50.0% to $137.0 million in 2024, then rose by 27.74% to $175.0 million in 2025, then decreased by 4.0% to $168.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Current Deferred Revenue are $168.0 million (Q1 2026), $175.0 million (Q4 2025), and $190.0 million (Q3 2025).